Bovicox 50 mg/ml oral suspension

Target Species: Cattle (calves). Sheep (lambs).

Treats & Controls:

Cattle: For the prevention of clinical signs of coccidiosis and reduction of oocyst shedding in housed calves replacing cows producing milk for human consumption (dairy cows) on farms with a confirmed history of coccidiosis caused by Eimeria bovis or Eimeria zuernii.

Sheep: For the prevention of clinical signs of coccidiosis and reduction of oocyst shedding in lambs on farms with a confirmed history of coccidiosis caused by Eimeria crandallis and Eimeria ovinoidalis.

Active Ingredient(s): Toltrazuril

Dosage: 

Cattle: Each animal: a single oral dose of 15 mg toltrazuril/kg body weight (i.e. 3.0 ml of the product/10 kg bw.). For the treatment of a group of animals of the same breed and same or similar age, the dosing should be done according to the heaviest animal of this group.

Sheep: Each animal: a single oral dose of 20 mg toltrazuril/kg body weight (i.e. 0.4 ml of the product/kg bw.). If animals are to be treated collectively rather than individually, they should be grouped according to their body weight and dosed accordingly, in order to avoid under- or over-dosing.

Withdrawal:

Cattle: Meat and offal: 63 days. Not authorised for use in animals producing milk for human consumption.

Sheep: Meat and offal: 42 days. Not authorised for use in animals producing milk for human consumption